FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

The FDA notes a supplemental application submission for APLENZIN (bupropion hydrobromide) from Bausch Health US, LLC, related to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• APLENZIN (BUPROPION HYDROBROMIDE)

Snippet

SUPPL AP for APLENZIN (BUPROPION HYDROBROMIDE)